Data / Form D filings / Pharmazz, Inc.
Pharmazz, Inc.: Form D filings
Pharmazz, Inc., a pharmaceuticals company in Willowbrook, IL, filed 13 Form D notices with the SEC between 2018 and 2026. The latest, on July 28, 2026, reports $250,000 sold of a $3.5 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 50 W 75TH ST STE 105, Willowbrook, IL, 60527
- Phone
- (630) 780-6087
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1729963
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 28, 2026 | New notice | $3,500,000 | $250,000 | $3,250,000 | 1 | Jul 13, 2026 | sec.gov |
| Jun 11, 2025 | New notice | $25,037,500 | $10,037,500 | $15,000,000 | 1 | May 27, 2025 | sec.gov |
| Aug 30, 2024 | New notice | $15,000,000 | $7,500,000 | $7,500,000 | 1 | Aug 15, 2024 | sec.gov |
| Feb 16, 2024 | New notice | $6,000,000 | $150,000 | $5,850,000 | 2 | Feb 2, 2024 | sec.gov |
| Nov 2, 2023 | New notice | $15,000,000 | $450,000 | $14,550,000 | 3 | Oct 24, 2023 | sec.gov |
| May 18, 2023 | New notice | $6,550,000 | $2,300,000 | $4,250,000 | 16 | Oct 18, 2022 | sec.gov |
| May 18, 2023 | Amendment | $5,450,000 | $5,450,000 | 28 | Apr 12, 2021 | sec.gov | |
| Apr 29, 2021 | New notice | $5,000,000 | $250,000 | $4,750,000 | 1 | Apr 12, 2021 | sec.gov |
| Mar 3, 2020 | New notice | $5,000,000 | $1,405,500 | $3,594,500 | 1 | Feb 14, 2020 | sec.gov |
| Nov 14, 2019 | Amendment | $3,691,000 | $3,691,000 | 23 | Jul 31, 2018 | sec.gov | |
| Aug 7, 2019 | New notice | $3,000,000 | $2,196,000 | $804,000 | 22 | Jul 31, 2018 | sec.gov |
| Aug 6, 2019 | Amendment | $723,603 | $723,603 | 16 | Jan 18, 2018 | sec.gov | |
| Feb 1, 2018 | New notice | $1,000,050 | $299,299 | $700,751 | 7 | Jan 18, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Sunil Gulati | Executive Officer | |
| David Costello | Executive Officer | |
| Dharminder Marwah | Executive Officer, Director | |
| James McDonnell | Director | |
| Jane Kiernan | Director | |
| Anil Gulati | Executive Officer, Director | |
| Atul Raut | Director |
Every Form D from the week of Jul 27, 2026 · All recent filings in Illinois · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Pharmazz, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.